165 related articles for article (PubMed ID: 31404062)
1. Immunosuppressive regimens based on Cyclophospamide or Calcineurin inhibitors: Comparison of their effect in the long term outcome of Primary Membranous Nephropathy.
Stangou M; Marinaki S; Papachristou E; Kolovou K; Sambani E; Zerbala S; Papadea P; Balafa O; Rapsomanikis KP; Andrikos A; Manolakaki P; Papadopoulou D; Mitsopoulos E; Liakou H; Andronikidi PE; Choulitoudi V; Moustakas G; Galitsiou D; Dafnis E; Stylianou K; Stefanidis I; Golfinopoulos S; Panagoutsos S; Tsilivigkou M; Papadogianakis A; Tzanakis I; Sioulis A; Vlachakos D; Grapsa E; Spaia S; Kaperonis N; Paliouras C; Dioudis C; Papoulidou F; Apostolou T; Iatrou C; Boletis I; Goumenos D; Papagianni A
PLoS One; 2019; 14(8):e0217116. PubMed ID: 31404062
[TBL] [Abstract][Full Text] [Related]
2. Calcineurin inhibitors or cyclophosphamide in the treatment of membranous nephropathy superimposed with FSGS lesions: a retrospective study from China.
He HG; Huang YY; Liang QQ; Ye QR; Li AD; Ye K; Wu QX; You YW
Ren Fail; 2023; 45(2):2253930. PubMed ID: 37724535
[TBL] [Abstract][Full Text] [Related]
3. Calcineurin inhibitors versus cyclophosphamide for idiopathic membranous nephropathy: A systematic review and meta-analysis of 21 clinical trials.
Qiu TT; Zhang C; Zhao HW; Zhou JW
Autoimmun Rev; 2017 Feb; 16(2):136-145. PubMed ID: 27988429
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological features and outcome in elderly patients with idiopathic membranous nephropathy.
Liang J; Hao W; Xia F; Zhao Z; Wu Y; Yu F; Hu W; Fang X; Liu W
Ren Fail; 2023 Dec; 45(1):2212081. PubMed ID: 37194712
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of the efficacy of different treatments for idiopathic membranous nephropathy: a retrospectively real-world study.
Sun M; Huang J; Dong J; Li Z; Li C; Zhang S; Chen B
Curr Med Res Opin; 2023 May; 39(5):761-769. PubMed ID: 36938631
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial.
Ramachandran R; Hn HK; Kumar V; Nada R; Yadav AK; Goyal A; Kumar V; Rathi M; Jha V; Gupta KL; Sakhuja V; Kohli HS
Nephrology (Carlton); 2016 Feb; 21(2):139-46. PubMed ID: 26205759
[TBL] [Abstract][Full Text] [Related]
7. Treatment preferences for primary membranous nephropathy: Results of a multinational survey among nephrologists in the South Asia Pacific region.
Bose B; Badve SV; Johnson DW; Hawley C; Jha V; Reidlinger D; Peh CA
Nephrology (Carlton); 2022 Jan; 27(1):35-43. PubMed ID: 34392579
[TBL] [Abstract][Full Text] [Related]
8. Response to immunosuppressive therapy in PLA
Wang J; Xie Q; Sun Z; Xu N; Li Y; Wang L; Liu S; Xue J; Hao CM
BMC Nephrol; 2017 Jul; 18(1):227. PubMed ID: 28693446
[TBL] [Abstract][Full Text] [Related]
9. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
Branten AJ; Wetzels JF
Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
[TBL] [Abstract][Full Text] [Related]
10. Effects of hydroxychloroquine on proteinuria in membranous nephropathy.
Cheng YJ; Cheng XY; Zhang YM; Wang F; Wang X; Meng LQ; Liu G; Cui Z; Zhao MH
J Nephrol; 2022 May; 35(4):1145-1157. PubMed ID: 34846713
[TBL] [Abstract][Full Text] [Related]
11. Recent Clinical Trials Insights into the Treatment of Primary Membranous Nephropathy.
Rojas-Rivera J; Fervenza FC; Ortiz A
Drugs; 2022 Feb; 82(2):109-132. PubMed ID: 34932208
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
von Groote TC; Williams G; Au EH; Chen Y; Mathew AT; Hodson EM; Tunnicliffe DJ
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD004293. PubMed ID: 34778952
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
du Buf-Vereijken PW; Wetzels JF
Nephrol Dial Transplant; 2004 Aug; 19(8):2036-43. PubMed ID: 15187191
[TBL] [Abstract][Full Text] [Related]
14. Comparison of cyclophosphamide and calcineurin inhibitors for idiopathic membranous nephropathy: A protocol for systematic review and meta-analysis.
Li K; Yu Y; Gao Y; Gao J
Medicine (Baltimore); 2022 Feb; 101(8):e28891. PubMed ID: 35212292
[TBL] [Abstract][Full Text] [Related]
15. Endoplasmic Reticulum Stress Predicts Clinical Response to Cyclosporine Treatment in Primary Membranous Nephropathy.
Tao J; Zhang W; Wen Y; Sun Y; Chen L; Li H; Li M; Li X; Lafayette RA; Li X
Am J Nephrol; 2016; 43(5):348-56. PubMed ID: 27166157
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppression therapy for idiopathic membranous nephropathy: systematic review with network meta-analysis.
Bose B; Chung EYM; Hong R; Strippoli GFM; Johnson DW; Yang WL; Badve SV; Palmer SC
J Nephrol; 2022 May; 35(4):1159-1170. PubMed ID: 35199314
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
Chen Y; Schieppati A; Chen X; Cai G; Zamora J; Giuliano GA; Braun N; Perna A
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004293. PubMed ID: 25318831
[TBL] [Abstract][Full Text] [Related]
18. Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial.
Hofstra JM; Branten AJ; Wirtz JJ; Noordzij TC; du Buf-Vereijken PW; Wetzels JF
Nephrol Dial Transplant; 2010 Jan; 25(1):129-36. PubMed ID: 19666912
[TBL] [Abstract][Full Text] [Related]
19. Early initiation of immunosuppressive treatment in membranous nephropathy patients.
Chan CK; Lai TS; Chen PM; Chou YH; Wu CF; Chiu YL; Chiang WC; Chen YM; Chu TS; Wu KD
J Formos Med Assoc; 2017 Apr; 116(4):266-275. PubMed ID: 28202222
[TBL] [Abstract][Full Text] [Related]
20. Cyclical cyclophosphamide and steroids is effective in resistant or relapsing nephrotic syndrome due to M-type phospholipase A2 receptor-related membranous nephropathy after tacrolimus therapy.
Ramachandran R; Kumar V; Jha V
Kidney Int; 2016 Jun; 89(6):1401-2. PubMed ID: 27181781
[No Abstract] [Full Text] [Related]
[Next] [New Search]
